A Cost Decision Model Supporting Treatment Strategy Selection in BRCA1/2 Mutation Carriers in Breast Cancer

In this paper, a cost decision-making model that compares the healthcare costs for diverse treatment strategies is built for BRCA-mutated women with breast cancer. Moreover, this model calculates the cancer treatment costs that could potentially be prevented, if the treatment strategy with the lowes...

Descripción completa

Detalles Bibliográficos
Autores principales: Carbonara, Nunzia, La Forgia, Daniele, Pellegrino, Roberta, Ressa, Cosmo, Tommasi, Stefania
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8470684/
https://www.ncbi.nlm.nih.gov/pubmed/34575624
http://dx.doi.org/10.3390/jpm11090847

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8470684/
https://www.ncbi.nlm.nih.gov/pubmed/34575624
http://dx.doi.org/10.3390/jpm11090847

Ejemplares similares